Bicara Therapeutics BCAX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's software and technology licenses, net?
- Bicara Therapeutics (BCAX) reported software and technology licenses, net of $6.91M in Q1 2026.
- How has Bicara Therapeutics's software and technology licenses, net changed year-over-year?
- Bicara Therapeutics's software and technology licenses, net increased by 4.1% year-over-year, from $6.64M to $6.91M.
- What is the long-term trend for Bicara Therapeutics's software and technology licenses, net?
- Over 2 years (2023 to 2025), Bicara Therapeutics's software and technology licenses, net has grown at a 81.7% compound annual growth rate (CAGR), from $2.09M to $6.91M.